Clinical Trials
- Diabetes
Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab (PROTECT)
- Ages8 years - 17 years
- GenderBoth
- Digestive System, Obesity & Weight Management
Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes after Bariatric Surgery
- Digestive System
test
- Ages18 years - 75 years
- GenderBoth